Javascript must be enabled to continue!
EFFECT OF STREPTOZOTOCIN‐INDUCED DIABETES ON NGF, P75(NTR) AND TRKA CONTENT OF PREVERTEBRAL AND PARAVERTEBRAL RAT SYMPATHETIC GANGLIA
View through CrossRef
Diabetic autonomic neuropathy results in significant morbidity and mortality. Both diabetic humans and experimental animals show neuroaxonal dystrophy of autonomic nerve terminals, particularly in the prevertebral superior mesenteric ganglia (SMG) and celiac ganglia (CG) which innervate the hyperplastic/hypertrophic diabetic small intestine. Previously, investigators suggested that disturbances in ganglionic nerve growth factor (NGF) content or transport might play a pathogenetic role in diabetic autonomic pathology. To test this hypothesis, we measured NGF content and NGF receptor expression, p75(NTR) (low affinity neurotrophin receptor) and trkA (high affinity NGF receptor), in control and diabetic rat SMG, CG and superior cervical ganglia (SCG). Surprisingly, rather than a decrease, we observed an approximate doubling of NGF content in the diabetic SMG and CG, a result which reflects increased NGF content in the hyperplastic diabetic alimentary tract. No change in NGF content was detected in the diabetic SCG which is relatively spared in experimental diabetic autonomic neuropathy. NGF receptor expression was not consistently altered in any of the autonomic ganglia. These observations suggest that increased NGF content in sympathetic ganglia innervating the diabetic alimentary tract coupled with intact receptor expression may produce aberrant axonal sprouting and neuroaxonal dystrophy.
Title: EFFECT OF STREPTOZOTOCIN‐INDUCED DIABETES ON NGF, P75(NTR) AND TRKA CONTENT OF PREVERTEBRAL AND PARAVERTEBRAL RAT SYMPATHETIC GANGLIA
Description:
Diabetic autonomic neuropathy results in significant morbidity and mortality.
Both diabetic humans and experimental animals show neuroaxonal dystrophy of autonomic nerve terminals, particularly in the prevertebral superior mesenteric ganglia (SMG) and celiac ganglia (CG) which innervate the hyperplastic/hypertrophic diabetic small intestine.
Previously, investigators suggested that disturbances in ganglionic nerve growth factor (NGF) content or transport might play a pathogenetic role in diabetic autonomic pathology.
To test this hypothesis, we measured NGF content and NGF receptor expression, p75(NTR) (low affinity neurotrophin receptor) and trkA (high affinity NGF receptor), in control and diabetic rat SMG, CG and superior cervical ganglia (SCG).
Surprisingly, rather than a decrease, we observed an approximate doubling of NGF content in the diabetic SMG and CG, a result which reflects increased NGF content in the hyperplastic diabetic alimentary tract.
No change in NGF content was detected in the diabetic SCG which is relatively spared in experimental diabetic autonomic neuropathy.
NGF receptor expression was not consistently altered in any of the autonomic ganglia.
These observations suggest that increased NGF content in sympathetic ganglia innervating the diabetic alimentary tract coupled with intact receptor expression may produce aberrant axonal sprouting and neuroaxonal dystrophy.
Related Results
Abstract TMP114: Modulation Of P75ntr Improves Neuroprotection Following Ischemic Stroke
Abstract TMP114: Modulation Of P75ntr Improves Neuroprotection Following Ischemic Stroke
Background:
Stroke is a serious cause of mortality in the United States. Tissue plasminogen activator (tPA) is the only effective drug. However, it increases the risk o...
Shugan Jiangni Hewei Granule regulates synaptic plasticity in central sensitization via NGF/TrkA Signaling Pathways in psychological stress rats with nonerosive reflux disease
Shugan Jiangni Hewei Granule regulates synaptic plasticity in central sensitization via NGF/TrkA Signaling Pathways in psychological stress rats with nonerosive reflux disease
Abstract
Objective. We sought to investigate the mechanism of visceral hypersensitivity improvement of Shugan Jiangni Hewei Granules (SJHG) treatment of non-erosive reflux ...
Nerve growth factor signalling in pathology and regeneration of human teeth
Nerve growth factor signalling in pathology and regeneration of human teeth
AbstractNerve growth factor (NGF) is a key regulator of the development and differentiation of neuronal and non-neuronal cells. In the present study we examined the distribution of...
Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor
Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor
Abstract
TU27, a mouse IgG1 mAb directed at the p75 chain of the human IL-2R, was analyzed for its ability to interact with IL-2 binding on isolated p75 chains (YT-2...
Yifei Decoction Regulates the NGF/TRKA/PI3K/AKT Signaling Axis to Inhibit the Epithelial–Mesenchymal Transformation and Proliferation of Pulmonary Epithelial Cells in Bleomycin‐Induced Pulmonary Fibrogenesis
Yifei Decoction Regulates the NGF/TRKA/PI3K/AKT Signaling Axis to Inhibit the Epithelial–Mesenchymal Transformation and Proliferation of Pulmonary Epithelial Cells in Bleomycin‐Induced Pulmonary Fibrogenesis
Background
It was important to find better therapeutic drugs for idiopathic pulmonary fibrosis (IPF), and in our previous study, Yifei decoction (YFT) alleviate...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...
Abstract 738: Design and synthesis of novel N10-protected pyrrolobenzodiazepine (PBD) prodrugs for use in nitroreductase-mediated GDEPT therapies
Abstract 738: Design and synthesis of novel N10-protected pyrrolobenzodiazepine (PBD) prodrugs for use in nitroreductase-mediated GDEPT therapies
Abstract
The over-expression of telomerase in cancer cells has been previously exploited for gene therapy strategies. One approach involves the use of a plasmid cont...

